Free Webinar: ISMPP U Plain Language Summaries of Publications
The International Society for Medical Publication Professionals (ISMPP) is offering a free talk covering plain language summaries (PLS) of publications [...]
New Independent Directors Appointed by Syneos
Syneos Health has announced that it has appointed Barbara W. Bodem and Alfonso G. Zulueta to its Board of Directors. [...]
Clarivate Releases 2022 Drugs to Watch List
Clarivate has released their 2022 Drugs to Watch list. The list includes seven experimental therapeutics in the pipeline that have [...]
Aduhelm Sparks Discourse about Equity in Alzheimer’s Care
The debate over systemic inequity in Alzheimer’s treatment has been stirred once again by Medicare’s proposal to only cover Aduhelm, [...]
Draft Ruling from CMS Suggests Narrow Coverage for Aduhelm
The Centers for Medicare & Medicaid Services (CMS) have released a draft ruling indicating it will only cover Biogen’s Alzheimer’s [...]
23andMe Begins Clinical Trial for Their First Drug
Clinical trials have begun for the now-ubiquitous DNA-testing company 23andMe’s new cancer drug. The immuno-oncology antibody, named 23ME-000610, targets solid [...]
Webinar: Adaptive Sample Size Reassessment – Conditional Powers or Bayesian Predictive Power?
Cytel’s Executive Research Principal, Rajat Mukherjee discusses using a Bayesian Predictive Power (PP) calculation for Adaptive Sample Size [...]
Jeeva Informatics eClinical Platform Improves Trials
The founder and CEO of Jeeva Informatics, Harsha Rajasimha, maintains that clinical trials are held back by inefficiency and inadequate [...]
Updated Promising Zone Design Improves Workflow and Clinical Trial Design for Biotechs
Promising Zone Design was first introduced a decade ago as a method to estimate sample size. The method is still [...]
Podcast on Clinical Trial Challenges and FDA Solutions
A recent episode of the Business of Biotech podcast series features Allan Shaw. This installment highlights some of the major problems arising [...]
Understanding the Power of Platform Trials
A recent Cytel blog post details the benefits of one category of the Master Protocol termed the platform trial, typically [...]
Science 37 Seeks Participants for Brief Survey on Clinical Trial Challenges and Future Outlook
Science 37 is conducting a survey on key challenges faced by clinical trial sponsors. The five-minute survey is blinded and [...]
Whitepaper Highlights the Benefits of Digital Data Collection
Signant Health has published a whitepaper that compares digital data collection with manual methods. A growing number of clinical trial [...]
Register for Upcoming Webinar on RWD in Decentralized Clinical Trials
A webinar highlighting the benefits of decentralized clinical trials that incorporate real world data (RWD) will take place on November [...]
Data Expert Discusses 9 RWE Applications in Healthcare and Pharma R&D
Vice President of Business Development & Real World Evidence (RWE) at ArborMetrix Benjamin Echeazu discusses the growing use of RWE [...]
Can AI Improve Patient Centricity in Clinical Trials?
According to a recent discussion with leaders at healthcare solutions company Sharecare, artificial intelligence (AI) can improve patient involvement in [...]
ICON Clinical Trial Experts Discuss the Intricacies of Rare Disease Studies
Two clinical trial experts at ICON shared their thoughts on clinical trial design, including important considerations and strategies for rare [...]
Patients as Partners Issues Call for Abstracts for March 2022 Annual Meeting
Patients as Partners welcomes abstracts to be considered for its March 2022 eighth annual meeting. This meeting includes more than [...]
ISPOR Webinar on Embedded Clinical Trials and RWE Now Available On-Demand
A recent webinar, sponsored by Syneos, focuses on the use of embedded clinical trials in generating real world evidence (RWE). [...]
Cytel Researcher Discusses Deciding Between Progress Free Survival and Overall Survival Endpoints in Clinical Trials
Determining whether to use progress free survival (PFS) or overall survival (OS) in clinical trials is an important yet challenging [...]
New Cytel Whitepaper on Clinical Trial Optimization Using Pareto Efficiency
Cytel’s new whitepaper on optimizing clinical trial design discusses how to best allocate resources. Thoughtfully planning a clinical trial requires [...]
Massive Bio Announces Partnership With Patient-Centered Group Self Care Catalysts and Veterans Prostate Cancer Awareness Non-Profit to Improve Clinical Trial Diversity and Oncology RWE
Massive Bio will partner with non-profit group Veterans Prostate Cancer Awareness (VPCa) and patient-centered organization Self-Care Catalysts to promote enrollment [...]
JMCP Article Details Payer Perceptions of Oncology RWD During Drug Launches
In a recent article published in the Journal of Managed Care and Specialty Pharmacy (JMCP), the authors discuss the use [...]
New Cytel Blog on Causal Inference and RWD in Decision Making
A new Cytel blog post discusses using real world data (RWD) to bypass phase IV clinical trials. In contrast to [...]
AbbVie HEOR Expert Notes Lack of Diversity Negatively Impacts Clinical Trials, RWD Offers Possible Solution
Vice President and Global Head of Health Economics and Outcomes Research (HEOR) at AbbVie Dr. Chris Boone notes that the [...]